Molecular Docking and In vitro Cytotoxic Activity of Novel 1,3,4-thiadiazole Derivatives Against MCF-7 Cell Line
AlQalam Journal of Medical and Applied Sciences · 30.05.2026
DOI: 10.54361/ajmas.269502 ↗Kurz gefasst
Fachartikel in der Zeitschrift AlQalam Journal of Medical and Applied Sciences, online erschienen am 02.05.2026. Verfasst von Mohamed Eleribi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
This investigation assesses the cytotoxic profiles and docking properties of twelve newly synthesized 1,3,4-thiadiazole derivatives against the MCF-7 cell line. The results revealed that nine of these compounds displayed noteworthy cytotoxic activity, with the most effective compound recording an IC50 value of 17.30 μM. Additionally, docking analyses indicated binding energies ranging from (-7.6 to -12.4 kcal/mol). In silico evaluations confirmed that all compounds are in alignment with Lipinski's Rule of Five. Moreover, the ADMET properties suggest that these synthesized derivatives are suitable for oral administration.
Zitieren
APA
Eleribi, M., Elabbar, F., & Baaiu, B. (2026). Molecular Docking and In vitro Cytotoxic Activity of Novel 1,3,4-thiadiazole Derivatives Against MCF-7 Cell Line. AlQalam Journal of Medical and Applied Sciences. https://doi.org/10.54361/ajmas.269502
Vancouver
Eleribi M, Elabbar F, Baaiu B. Molecular Docking and In vitro Cytotoxic Activity of Novel 1,3,4-thiadiazole Derivatives Against MCF-7 Cell Line. AlQalam Journal of Medical and Applied Sciences. 2026. doi:10.54361/ajmas.269502
BibTeX
@article{Eleribi2026,
author = {Eleribi, Mohamed and Elabbar, Fakhri and Baaiu, Basma},
title = {Molecular Docking and In vitro Cytotoxic Activity of Novel 1,3,4-thiadiazole Derivatives Against MCF-7 Cell Line},
journal = {AlQalam Journal of Medical and Applied Sciences},
year = {2026},
doi = {10.54361/ajmas.269502}
}
EUVIMED